Focus is on expanding Sciex’s footprint within the Americas' biopharma market by enhancing customer relationships, prospecting business opportunities, negotiating complex deals, and initiating new product evaluations at CoE. Product offering consists of a novel, automated high-throughput screening (HTS) workflow that offers speed, scale, and precision utilizing the EchoMS+ technology. This solution for drug discovery is customizable and provides quantitation and enhanced characterization of target drug compounds. Target areas for tech: HTS, med chem, compound library QA, HT-ADME, oligos, PFAS, and DoA.Accomplishments to-date:-Heavy contributor to the successful EchoMS+ product launch in June '24, selling very first unit globally. Quickly secured an additional 2 sales with another 5 units currently forecasted to close by EOY (initial 6 mo.; ~$8M). For H1 20024, 140% AOP.-Revitalization of product pipeline in first year on the job. Management of ~100 opportunities in Americas. Pipeline improved by over $3M y/y landing 4 sales totaling ~$4M. Lead conversion improved +10% y/y, and lead generation improved +20% y/y.-Engaged in commercial partnerships with Beckman Coulter, High Res Bio, and Biosero.-Organized successful workshop on EchoMS technology in May 2023. 140 total registrants with over 80 in attendance for a four-hour event.-Served as chief organizer for global SLAS 2023 Conference - San Diego in Feb. 2023, planning all booth activity, breakfast workshop (standing room only), meetings, and scientific poster presentations. 200 new leads generated at event (target was 40). -Executed global BD strategy for new product release. Participated in strategic planning workshops, presenting routinely to executive leadership and global colleagues. DBS & Kaizen principles utilized. Sought gemba and eliminated muda.-Put competitive pricing in place as well as led 4 top-notch sales execs in focused sales efforts re: EchoMS®.-Forecasting and QBR update mastery.

Working with a global team, my new role will be centered on expanding Taconic’s footprint – both products and services - within the North American CRO market segment. Focus will be enhancing current customer relationships, prospecting for new accounts, establishing new business opportunities (win-win & synergistic in nature), negotiating complex deals, forming collaborations, and initiating new product evaluations. Efforts will embody Taconic’s key differentiators within the marketplace of being customer centric as well as enablers of solutions in addition to serving as a research consultant/partner.Key accomplishments in first 2 quarters:-Achieved 111% AOP-Landed 3 large orders for off-the-shelf products totaling nearly $400K-Expanded into a new product portfolio for market segment, breeding services, which resulted in 17 projects tallying $260K in revenue-Realized y/y growth at top 6 accounts of $900K; won business from 13 new logos; identified new opportunity valued at $981K involving Taconic's humanized lines-Championed legal agreement (MSA-Master Service Agreement) execution; 18 drafted with 6 fully executed; 2 were for global firms based out of China-Participated in onsite travel (5 trips, 8 cities, 18 in-person meetings w/ 58 folks, and 6 business meals) as well as conducted several virtual meetings (140 in total)-Initiated SOD1 rat collaboration (ALS Assoc. model) with Inotiv in Boulder, CO; 3-way collaboration; also worked on a new product launch collaboration between Eli Lilly in San Diego (Immunology) & Taconic - biz dev initiative-Participant in CRO market segment strategic building block with members of Taconic's senior leadership team (CCO & VP) in order to identify potential capabilities partnerships for company-Conducted extensive financial analyses on commercial product profitability by market segment as well as product code for Commercial VP & Product Mgt. team-Improved Salesforce data integrity - fixed over 800 errors totaling $1.2M

Commercial sales executive responsible for developing strategy and generating revenue growth at global pharmaceutical accounts, including firm's top account Eli Lilly and AbbVie. ~$11M overall territory size.Product line comprised of genetically engineered rodent models utilized in pharmaceutical research in the pre-clinical space for the development of therapeutics for cardiovascular and metabolic disease, immunology and inflammation, infectious disease, neuroscience, and oncology. Service offerings consisting of genetically engineered custom model generation/design and breeding.Top technical applications: in vivo R&D, immuno-oncology, CRISPR/Cas9 gene editing, NASH, genetic drift, cytokines, and the microbiome.For 2019, attained 16% over quota and YoY revenue growth of 20.5% (increase of >$1.8M). President's Council recipient. 2020 Scientific Services Award recipient.Landed first ever custom model generation project in company's history from AbbVie along with sizable $750K off-the-shelf immunodeficient model order. Other large orders registered for custom model generation/design at Eli Lilly & an off-the-shelf mouse line for BASi (each $500K new revenue).Global sales strategic account management lead for AbbVie, including all sites in North America and Europe.Represented Taconic at global tradeshows & conferences, including AACR, Discovery on Target, & AALAS.Organized educational seminar from 3 prestigious Eli Lilly scientists for lay staff at Taconic's Indiana barrier facility.Responsible for generating quarterly strategic territory & account plans, weekly forecasts, conducting onsite customer presentations & seminars, managing sales pipeline via Salesforce.com, facilitating execution of legal agreements, and developing annual pricing for key accounts. Selected by senior sales leadership to generate weekly forecast report for entire NA academic & commercial sales teams. Served as new hire mentor.

Sample Prep and Analysis of Nucleic Acid (DNA + RNA), Protein, and Cells (B2B & outside sales)Responsible for firm's automated liquid handling, microplate, and purification portfolio. Platforms include bulk dispensing, KingFisher & Versette robotics, plate readers/washers/incubators/shakers, thermal cyclers, qPCR instruments, and purification products (e.g. magnetic particles for DNA/RNA/protein/cell purification & mass spec immunoassay - MSIA). Technology utilized in molecular biology and immunoassay (e.g. ELISA) workflows. Product line is comprised of both capital equipment and consumables, such as MagMAX branded reagent kits.Since starting position in 2014, I have attained 100% of revenue growth goal. Annual actual growth has averaged 10.1% over 4 years. ~$6M overall territory size.2017 Performance: 108% attainment and 13.4% growth YOY.Improved revenue 54.7% during first quarter on the job.2015 Performance: Q1 - 105% to plan, Q2 - 147% to plan, Q3 - 155% to plan, Q4 - 233% to plan, YTD - 159% to plan; top division performer in Q1 + Q2 + Q3 + Q4; 76% revenue growth YOY2015 Honors: Circle of Excellence (e.g. top sales performer) & Field Sales Rookie of the YearMember of 2016 President's CouncilMember of 2016-2017 Leadership Advisory Council - focus is improving career development & advancement within the companySold first two KingFisher Presto units in 2016. First sales rep. in globe to do so.Dug up 2 sizable opportunities that could result in significant business in 2018 (50 units per opportunity at 2 separate accounts; $3M total projected revenue).Participated in internal learning sessions on strategic action planning (STRAP) & annual operating plan (AOP) formation. Took part in job interview process and hiring of new sales candidates. Served as mentor to new hire representing NYC and surrounding geography.Participant in 12 month internal mentoring/coaching pilot program - Flex Coach Network.Mastery of Salesforce.com & Concur

Ensured successful rollout of planning and strategy related to all aspects of Perfinity technology through identification and follow-up with 5000+ leads securing the sale of 20 workstation platforms worth $150K each in both domestic and international markets within first 3 years of product release.Contributed to business development, marketing, and strategic aspects of organization, assisting with business plans, pricing, forecasting, market analyses, email blasts, website, and press releases.Cultivated commercial partnerships with Thermo Scientific, AB Sciex, Shimadzu, Life Technologies, and Eppendorf.Envisioned, structured and conducted technology presentations at forums and seminars including Mayo Clinic, CDC, Bristol-Myers Squibb, Genentech, NCI Site Visit, MSACL, and CPSA.Responsible for multiple board level presentations and technical update at Shareholders’ meetings.

Performed platform installation and training at Genentech, Einstein College of Medicine, Purdue, AIT Bioscience & Shimadzu USA.Organized and participated in industry conferences and tradeshows, securing the greatest # of leads on behalf of Perfinity and partnering company, Shimadzu Scientific Instruments, at ASMS 2011. Developed new product positioning that differentiated solutions through development of novel LC-MS based automated sample prep platform for protein analysis, involving extensive work with separations, chromatography and mass spectrometry. Championed animation and financial assessment of Perfinity platforms in addition to R&D Magazine Award submission.

Performed grant writing and submission as well as exposure to regulated work environments, adhering to cGMP & GLP standards.Created and led quarterly business presentations to management team reporting detailed data analysis and progress on short and long-term initiatives.